KR102386018B1 - 진행된 비알코올성 지방 간염의 치료 방법 - Google Patents

진행된 비알코올성 지방 간염의 치료 방법 Download PDF

Info

Publication number
KR102386018B1
KR102386018B1 KR1020167032148A KR20167032148A KR102386018B1 KR 102386018 B1 KR102386018 B1 KR 102386018B1 KR 1020167032148 A KR1020167032148 A KR 1020167032148A KR 20167032148 A KR20167032148 A KR 20167032148A KR 102386018 B1 KR102386018 B1 KR 102386018B1
Authority
KR
South Korea
Prior art keywords
compound
pharmaceutical composition
formula
patient
nash
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020167032148A
Other languages
English (en)
Korean (ko)
Other versions
KR20170003581A (ko
Inventor
카즈코 마츠다
유이치 이와키
Original Assignee
메디시노바, 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 메디시노바, 인크. filed Critical 메디시노바, 인크.
Publication of KR20170003581A publication Critical patent/KR20170003581A/ko
Application granted granted Critical
Publication of KR102386018B1 publication Critical patent/KR102386018B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/22—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/121—Ketones acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • Y10S514/894—

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Alcoholic Beverages (AREA)
  • Steroid Compounds (AREA)
KR1020167032148A 2014-05-08 2015-05-06 진행된 비알코올성 지방 간염의 치료 방법 Active KR102386018B1 (ko)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201461990606P 2014-05-08 2014-05-08
US61/990,606 2014-05-08
US201462042072P 2014-08-26 2014-08-26
US62/042,072 2014-08-26
US14/490,618 US9346754B2 (en) 2014-05-08 2014-09-18 Method of treating advanced non-alcoholic steatohepatitis
US14/490,618 2014-09-18
PCT/US2015/029457 WO2015171755A2 (en) 2014-05-08 2015-05-06 Method of treating advanced non-alcoholic steatohepatitis

Publications (2)

Publication Number Publication Date
KR20170003581A KR20170003581A (ko) 2017-01-09
KR102386018B1 true KR102386018B1 (ko) 2022-04-14

Family

ID=54367221

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020167032148A Active KR102386018B1 (ko) 2014-05-08 2015-05-06 진행된 비알코올성 지방 간염의 치료 방법

Country Status (10)

Country Link
US (1) US9346754B2 (enExample)
EP (1) EP3139911B1 (enExample)
JP (1) JP6672173B2 (enExample)
KR (1) KR102386018B1 (enExample)
CN (1) CN106456576A (enExample)
BR (1) BR112016025369A2 (enExample)
CA (2) CA2946597C (enExample)
ES (1) ES2964286T3 (enExample)
TW (1) TW201622716A (enExample)
WO (1) WO2015171755A2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9457306B2 (en) * 2014-10-07 2016-10-04 Life Technologies Corporation Regulated vacuum off-gassing of gas filter for fluid processing system and related methods
EP4346783A1 (en) * 2021-05-28 2024-04-10 MediciNova, Inc. Phenoxyalkylcarboxylic acid derivatives and their use in lowering triglyceride levels

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130158123A1 (en) * 2011-12-08 2013-06-20 Medicinova, Inc. Method of treating non-alcoholic fatty liver disease and steatohepatitis

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2585246A1 (fr) 1985-07-26 1987-01-30 Cortial Procede d'obtention de formes pharmaceutiques solides a liberation prolongee
US4788055A (en) 1985-12-09 1988-11-29 Ciba-Geigy Corporation Resinate sustained release dextromethorphan composition
GB8613689D0 (en) 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
GB8613688D0 (en) 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
US4816264A (en) 1986-06-06 1989-03-28 Warner-Lambert Company Sustained release formulations
US4985585A (en) 1988-03-07 1991-01-15 Kyorin Pharmaceutical Co., Ltd. Phenoxyalkylcarboxylic acid derivatives and process for their preparations
US4996047A (en) 1988-11-02 1991-02-26 Richardson-Vicks, Inc. Sustained release drug-resin complexes
CA2002492A1 (en) 1988-11-11 1990-05-11 Sandra T. A. Malkowska Pharmaceutical ion exchange resin composition
US5133974A (en) 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
US5290812A (en) 1991-01-18 1994-03-01 Kyorin Pharmaceutical Co., Ltd. Phenoxyalkylcarboxylic acid derivatives and process of preparing the same
US7060854B2 (en) 2003-06-24 2006-06-13 Medicinova, Inc. Process for making polymorphic form A of 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid
US7064146B2 (en) 2003-06-24 2006-06-20 Medicinova, Inc. Pharmaceutical compositions of isolated orthorhombic crystalline 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid and methods of use
MXPA06012564A (es) * 2004-04-27 2007-01-31 Medicinova Inc Derivados de acido fenoxialquilcarboxilico en el tratamiento de enfermedades inflamatorias.
WO2009109525A1 (en) * 2008-03-03 2009-09-11 Nycomed Gmbh Use of a specific pde4 inhibitor for the treatment and/or prophylaxis of non-alcoholic fatty liver disease
JP2013056834A (ja) * 2011-09-07 2013-03-28 Okayama Univ 線維化疾患治療剤

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130158123A1 (en) * 2011-12-08 2013-06-20 Medicinova, Inc. Method of treating non-alcoholic fatty liver disease and steatohepatitis

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Clinics in Liver Disease, 8(3), 549-558, 2004.
DDW Abstract Supplement to Gastroenterology, 142(5), S-543, 2012.
The American Journal of Gastorenterology, 94(9), 2467-2474, 1999.

Also Published As

Publication number Publication date
BR112016025369A2 (pt) 2017-08-15
CA3205812A1 (en) 2015-11-12
KR20170003581A (ko) 2017-01-09
CA2946597C (en) 2023-09-12
WO2015171755A2 (en) 2015-11-12
ES2964286T3 (es) 2024-04-05
JP2017518967A (ja) 2017-07-13
EP3139911A4 (en) 2017-12-20
EP3139911A2 (en) 2017-03-15
CN106456576A (zh) 2017-02-22
EP3139911B1 (en) 2023-10-25
US9346754B2 (en) 2016-05-24
CA2946597A1 (en) 2015-11-12
US20150322004A1 (en) 2015-11-12
JP6672173B2 (ja) 2020-03-25
TW201622716A (zh) 2016-07-01

Similar Documents

Publication Publication Date Title
JP2019218379A (ja) 肝障害の治療方法
JP6608404B2 (ja) 非アルコール性脂肪性肝疾患及び非アルコール性脂肪性肝炎の処置方法
KR102386018B1 (ko) 진행된 비알코올성 지방 간염의 치료 방법
TWI631943B (zh) 治療脂肪肝疾病之方法
KR102445077B1 (ko) 특발성 폐 섬유증의 치료 방법
US20190374505A1 (en) Methods and compositions for the treatment of non-alcoholic steatohepatitis
JP2022533603A (ja) １５－ＨＥＰＥおよび／または１５－ＨＥＴｒＥを含む組成物、ならびに心血管代謝性疾患、メタボリックシンドローム、および／または関連疾患を治療または予防する方法
US20230355596A1 (en) Compositions and methods of using nmdar inhibitors and kinase inhibitors to treat liver cancer
US20150320705A1 (en) Method of inhibiting or treating amyotrophic lateral sclerosis with phenoxyalkylcarboxylic acids
WO2010110268A1 (ja) 細胞死を予防するための医薬剤

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20161117

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
AMND Amendment
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20200427

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20210601

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20211101

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20210601

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

AMND Amendment
PX0901 Re-examination

Patent event code: PX09011S01I

Patent event date: 20211101

Comment text: Decision to Refuse Application

Patent event code: PX09012R01I

Patent event date: 20210802

Comment text: Amendment to Specification, etc.

Patent event code: PX09012R01I

Patent event date: 20200427

Comment text: Amendment to Specification, etc.

PX0701 Decision of registration after re-examination

Patent event date: 20220302

Comment text: Decision to Grant Registration

Patent event code: PX07013S01D

Patent event date: 20220203

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

Patent event date: 20211101

Comment text: Decision to Refuse Application

Patent event code: PX07011S01I

Patent event date: 20210802

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

Patent event date: 20200427

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

X701 Decision to grant (after re-examination)
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20220408

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20220411

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20250317

Start annual number: 4

End annual number: 4